Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway

  1. Palacios-Ramirez, R.
  2. Soulié, M.
  3. Fernandez-Celis, A.
  4. Nakamura, T.
  5. Boujardine, N.
  6. Bonnard, B.
  7. Bamberg, K.
  8. Lopez-Andres, N.
  9. Jaisser, F.
Journal:
Clinical science (London, England : 1979)

ISSN: 1470-8736

Year of publication: 2024

Volume: 138

Issue: 16

Pages: 1025-1038

Type: Article

DOI: 10.1042/CS20240302 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus